Plain-English translation of NCT07012486 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether dihydroartemisinin (DHA), a new oral medication, can help treat female pattern hair loss when combined with minoxidil, a topical treatment you apply to your scalp. Researchers want to see if women who take this medication plus use minoxidil experience more hair regrowth than those using minoxidil alone. The study will follow participants for 6 months with monthly clinic visits.
Female pattern hair loss is common and difficult to treat, and current options are limited. This trial is exploring whether this medication could offer women a new, more effective treatment option when added to existing therapies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups: one group will take a daily oral medication plus use minoxidil on their scalp, while the other group will use minoxidil alone. You will visit the clinic once each month for 6 months for checkups and tests to measure whether your hair is regrowing. The study will help researchers understand if the new medication improves results beyond minoxidil by itself.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
China